[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Wyrobnik TA, Ducci A, Micheletti M. Advances in human mesenchymal stromal cell-based therapies - Towards an integrated biological and engineering approach. Stem Cell Res. 2020;47:101888.
Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, et al. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. J Parkinsons Dis. 2024.
Wysocka J, Rossant J. 2018 ISSCR Strategic Planning: Looking to the Future. Stem Cell Reports. 2019;12(6):1183-1185.
M Wysocki A, Feranec RS, Tseng ZJack, Bjornsson CS. Using a Novel Absolute Ontogenetic Age Determination Technique to Calculate the Timing of Tooth Eruption in the Saber-Toothed Cat, Smilodon fatalis. PLoS One. 2015;10(7):e0129847.
Wysoczynski M, Hong KU, Moore JB. Bone marrow cell therapies in ischemic cardiomyopathy. Expert Opin Biol Ther. 2014:1-4.
Wysokińska E, Kolak A, Starosławska E, Kieszko D, Kamińska M, Surdyka D, Mocarska A, Burdan F. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma]. Pol Merkur Lekarski. 2015;38(227):280-282.
Wyspianska B, Bannister AJ, Barbieri I, Nangalia J, Godfrey A, Calero-Nieto FJ, Robson S, Rioja I, Li J, Wiese M, et al. BET protein inhibition shows efficacy against JAK2V617F driven neoplasms. Leukemia. 2013.
Wyszatko K, Janzen N, Silva LRafael, Kwon L, Komal T, Ventura M, Venugopal C, Singh SK, Valliant JF, Sadeghi S. Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs. EJNMMI Res. 2024;14(1):29.
Wytiaz V, Schwartz E, Rice JD, Zhao L, Jasty R, Schuetze S, Chugh R. Disparate Outcomes, Biologic and Therapeutic Differences in Pediatric versus Adult Patients with Ewing Sarcoma. Oncology. 2023.
Wytrwal M, Szmajnta K, Kucharski M, Nowak J, Oclon E, Kepczynski M. Kartogenin-loaded liposomes coated with alkylated chondroitin sulfate for cartilage repair. Int J Pharm. 2023:123436.
Włodarczyk M, Wieczorkiewicz-Kabut A, Białas K, Koclęga A, Noster I, Zielińska P, Helbig G. Real-Life Data on Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: Single-Center Analysis. Turk J Haematol. 2024.
X Y Zheng G, Do BT, Webster DE, Khavari PA, Chang HY. Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs. Nat Struct Mol Biol. 2014.
Xagorari A, Siotou E, Yiangou M, Tsolaki E, Bougiouklis D, Sakkas L, Fassas A, Anagnostopoulos A. Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury. Int J Clin Exp Pathol. 2013;6(5):831-40.
Xapelli S, Agasse F, Sardà-Arroyo L, Bernardino L, Santos T, Ribeiro FF, Valero J, Bragança J, Schitine C, Reis RA de Melo, et al. Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures. PLoS One. 2013;8(5):e63529.
Xapelli S, Agasse F, Grade S, Bernardino L, Ribeiro FF, Schitine CS, Heimann AS, Ferro ES, Sebasti AM, Reis RA de Melo, et al. Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?. Front Cell Neurosci. 2014;8:59.
Xavier E, Cornillon J, Ruggeri A, Chevallier P, Cornelissen JJ, Andersen NS, Maillard N, Nguyen S, Blaise D, Deconinck E, et al. Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: a Study on Behalf of Eurocord and Cord Blood Committee of Celular Therapy and Immunobiology Working Party(CTIWP), Chronic Malignancies Working Pa. Biol Blood Marrow Transplant. 2015.
Xavier M, Oreffo ROC, Morgan H. Skeletal stem cell isolation: A review on the state-of-the-art microfluidic label-free sorting techniques. Biotechnol Adv. 2016.
Xavier M, Kyriazi M-E, Lanham S, Alexaki K, Matthews E, El-Sagheer AH, Brown T, Kanaras AG, Oreffo ROC. Enrichment of Skeletal Stem Cells from Human Bone Marrow Using Spherical Nucleic Acids. ACS Nano. 2021.
Xavier FDias, de Farias DLeão Cord, Neto AElias Hall, Ribeiro GNogueira, de Araujo MAurelio Sa, Carneiro TXavier, Baiocchi OCesar Carv. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability. Oncotarget. 2023;14:977-994.
Xhaard A, Villate A, Hamane S, Michonneau D, Menotti J, Robin M, de Fontbrune FSicre, Dhedin N, de la Tour RPeffault, Socié G, et al. A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients. Bone Marrow Transplant. 2022.
Xhaard A, Xhaard C, Rubio M-T, Berceanu A, Botella-Garcia C, Coman T, Tavernier E, Labussière-Wallet H, Chevallier P, Legrand F, et al. A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort study. Br J Haematol. 2023.
Xhaard A, Bouton M, Delugin L, Giraud C, Guyon A, Giroux-Lathuile C, Hajjout K, Nicolas P, Peyrard T, Ratie V, et al. [Transfusion management and immuno-hematological follow-up after allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2023.
Xhabija B, Kidder BL. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer. Semin Cancer Biol. 2018.
Xi H, Kurtoglu M, Lampidis TJ. The wonders of 2-deoxy-d-glucose. IUBMB Life. 2014.
Xi G, Hayes E, Lewis R, Ichi S, Mania-Farnell B, Shim K, Takao T, Allender E, Mayanil CS, Tomita T. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. Oncogene. 2015.